Related Experiment Video
Updated: Jun 17, 2026

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
A meta-analysis on the efficacy of topical tranexamic acid for epistaxis: Does the method of administration affect
Mansoureh Fatahi1, Saba Aghajani2, Yahya Samadi3
1Surgi-Art Hospital, Lusail, Qatar.
Background:
Topical Tranexamic Acid is increasingly used for epistaxis, but previous evidence syntheses have reported low certainty due to small sample sizes and high heterogeneity. We aimed to evaluate the efficacy of topical tranexamic acid in adult anterior epistaxis and identify clinical factors, specifically the method of administration, that influence treatment success.
Methods:
We systematically searched PubMed, Embase, SCOPUS, and Web of Science for studies comparing topical tranexamic acid to standard care (nasal packing, vasoconstrictors, or placebo) for spontaneous anterior epistaxis. The primary outcome was bleeding cessation within 10 min. Secondary outcomes included emergency department length of stay and rebleeding rates (early and late). A subgroup analysis was conducted to compare the effects of different delivery methods on the success rate.
Results:
Eighteen studies (16 RCTs, 2 prospective cohorts) involving 2760 patients were included. Topical tranexamic acid significantly reduced the mean time required to bleeding cessation, with a mean difference of -4.68 (95% CI -7.02; -2.34). Furthermore, it enhanced the probability of achieving bleeding cessation within 10 min (OR 2.54; 95% CI 1.22; 5.29) and reduced the risk of both early rebleeding (OR 0.42; 95% CI 0.29; 0.59) and late rebleeding (OR 0.45; 95% CI 0.24; 0.87). Patients treated with tranexamic acid were five times more likely to be discharged from the ED within two hours (OR 5.53). Subgroup analysis revealed that the method of administration was a critical moderator: tranexamic acid-saturated gauze provided a robust, consistent benefit (OR 2.98), whereas atomized delivery yielded inconsistent results (OR 0.29). Sensitivity analysis restricted to RCTs confirmed the stability of the primary effect (OR 2.50).
Conclusion:
Topical TXA could be superior to traditional management strategies for adult anterior epistaxis, offering faster hemostasis, reduced rebleeding, and shorter emergency department stays. However, efficacy is technique-dependent; saturated gauze/pledgets should be preferred over atomized delivery to ensure optimal and consistent treatment effect.
Related Concept Videos
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Local Anesthetics: Pharmacokinetics
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...